Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Svennilson Peter
Relationship:   Director, 10% Owner
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   21,988,435    

Indirect Shares

   28,546,447      
Direct Value   $116,391,392    

Indirect Value

   $278,020,308      
Total Shares   50,534,882      
Total Value   $394,411,700      


Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $825,885 Nurix Therapeutics, Inc. $0 Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $825,885 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    32   
    4    

     Stock price went up :
    32   
    1    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   32.0   
   32.0   
     Percentage Gain/Loss :
   66.6%
 -51.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ Managing Partner, 10% ... 2019-04-02 0 2017-10-27 6,642,942    Premium*  
            Constellation Pharmaceuticals Inc CNST 10% Owner 2021-02-17 2,584,957 2021-02-17 3,645,681    Premium*  
            Gritstone Oncology, Inc. GRTS Director, 10% Owner 2018-10-02 0 2018-10-02 3,102,934    Premium*  
            Ngm Biopharmaceuticals Inc NGM Managing Partner, 10% ... 2020-08-28 17,988,843 2020-08-28 190,000    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Director, 10% Owner 0 2020-04-28 4,768,181    Premium*  
            Revolution Medicines, Inc. RVMD Director 2021-04-28 20,302 2021-04-28 3,145,258    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Rapt Therapeutics, Inc. RAPT Director, 10% Owner 2020-08-17 0 2020-09-22 5,630,497    Premium*  
* Premium Members only  

Records found :    116         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-14 4 B $10.36 $361,564 I/I 34,900 16,254,979 2.25 -
NGM Ngm Biopharmaceuticals In... 10% Owner   –       –       •   2019-10-10 4 B $10.50 $186,102 I/I 17,724 16,202,355 1.5 -
NGM Ngm Biopharmaceuticals In... 10% Owner   –       –       •   2019-10-11 4 B $10.57 $187,343 I/I 17,724 16,220,079 1.5 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-17 4 B $10.62 $72,407 I/I 6,818 16,329,897 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-18 4 B $11.29 $392,000 I/I 34,721 16,364,618 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-19 4 B $11.59 $1,720,698 I/I 148,464 16,760,815 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-23 4 B $11.63 $1,981,601 I/I 170,387 17,074,284 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-20 4 B $11.77 $1,684,075 I/I 143,082 16,903,897 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-23 4 B $11.86 $24,752 I/I 2,087 16,412,405 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-21 4 B $11.94 $518,196 I/I 43,400 16,408,018 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-11-04 4 B $11.99 $100,824 I/I 8,409 16,420,814 2.25 -
IMDZ Immune Design Corp. Director   –       •       •   2014-07-29 4 B $12.00 $4,788,192 I/I 399,016 3,161,942 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-22 4 B $12.00 $27,600 I/I 2,300 16,410,318 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-11-11 4 B $12.00 $180 I/I 15 16,420,829 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-24 4 B $12.22 $1,568,767 I/I 128,377 17,202,661 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-01 4 B $12.26 $1,447,501 I/I 118,067 17,441,211 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-02 4 B $12.40 $184,140 I/I 14,850 17,456,061 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-03 4 B $12.41 $181,025 I/I 14,587 17,470,648 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-25 4 B $12.49 $30,176 I/I 2,416 17,205,077 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-31 4 B $12.53 $1,479,380 I/I 118,067 17,323,144 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-23 4 B $13.35 $410,535 I/I 30,760 15,813,805 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-25 4 B $13.37 $411,294 I/I 30,753 15,873,612 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-04 4 B $13.39 $168,764 I/I 12,600 15,581,614 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-06 4 B $13.40 $168,884 I/I 12,600 15,594,214 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-05-20 4 B $13.50 $675,000 I/I 50,000 15,569,014 2.25 -
  116  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us